Zachary Jennifer 4
4 · Merck & Co., Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Zachary Jennifer
EVP, General Counsel
Transactions
- Exercise/Conversion
Common Stock
2024-02-02$87.10/sh+19,417$1,691,221→ 78,556.76 total - Sale
Common Stock
2024-02-02$126.97/sh−49,499$6,284,779→ 29,057.76 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-02−19,417→ 38,835 totalExercise: $87.10From: 2023-05-03Exp: 2032-05-02→ Common Stock (19,417 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.8650 to $127.3000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Holdings include shares acquired in dividend reinvestment transactions.
- [F3]The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.